Abiomed
ABMD
#1257
Rank
NZ$29.73 B
Marketcap
NZ$659.55
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Cash on Hand

Cash on Hand as of September 2022 : NZ$1.42 Billion

According to Abiomed's latest financial reports the company has NZ$1.42 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Abiomed - Cash on Hand chart (from 2013 to 2022)

Cash on Hand by year

Year Cash on Hand Change
2022-03-31NZ$1.09 B30.9%
2021-03-31NZ$0.83 B12.26%
2020-03-31NZ$0.74 B3.33%
2019-03-31NZ$0.72 B43.93%
2018-03-31NZ$0.50 B52.69%
2017-03-31NZ$0.32 B7.01%
2016-03-31NZ$0.30 B72.88%
2015-03-31NZ$0.17 B100.81%
2014-03-31NZ$88.25 M-3.62%
2013-03-31NZ$91.57 M-2.66%
2012-03-31NZ$94.07 M18.65%
2011-03-31NZ$79.28 M-3.69%
2010-03-31NZ$82.32 M-18.37%
2009-03-31NZ$0.10 B111.69%
2008-03-31NZ$47.63 M-54.63%
2007-03-31NZ$0.10 B106.07%
2006-03-31NZ$50.94 M-12.68%
2005-03-31NZ$58.34 M42.53%
2004-03-31NZ$40.93 M-58.37%
2003-03-31NZ$98.33 M-39.24%
2002-03-31NZ$0.16 B-30.52%
2001-03-31NZ$0.23 B8.33%
2000-03-31NZ$0.21 B532.71%
1999-03-31NZ$33.98 M-28.88%
1998-03-31NZ$47.78 M254.63%
1997-03-31NZ$13.47 M-13.31%
1996-03-31NZ$15.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Teleflex
TFX
NZ$0.61 B-56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$2.20 B 55.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$0.25 B-81.98%๐Ÿ‡บ๐Ÿ‡ธ USA